Clinical Protocol to Prevent Thrombogenic Effect of Liver-Derived Mesenchymal Cells for Cell-Based Therapies

The efficacy of mesenchymal stem cell infusion is currently tested in numerous clinical trials. However, therapy-induced thrombotic consequences have been reported in several patients. The aim of this study was to optimize protocols for heterologous human adult liver-derived progenitor cell (HHALPC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Coppin, Louise, Najimi, Mustapha, Bodart, Julie, Rouchon, Marie-Sophie, van der Smissen, Patrick, Eeckhoudt, Stéphane, Dahlqvist, Géraldine, Castanares-Zapatero, Diego, Komuta, Mina, Brouns, Sanne L., Baaten, Constance C., Heemskerk, Johan W. M., Horman, Sandrine, Belmonte, Nathalie, Sokal, Etienne, Stéphenne, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721739/
https://www.ncbi.nlm.nih.gov/pubmed/31394759
http://dx.doi.org/10.3390/cells8080846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721739/
https://www.ncbi.nlm.nih.gov/pubmed/31394759
http://dx.doi.org/10.3390/cells8080846

Ejemplares similares